UTMD
UTMD
NASDAQ · Health Care

Utah Medical Products Inc

$73.03
+0.17 (+0.23%)
As of Nov 14, 2:18 AM ET ·
Financial Highlights (FY 2026)
Revenue
36.60M
Net Income
10.72M
Gross Margin
57.1%
Profit Margin
29.3%
Rev Growth
-9.7%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 57.1% 57.1% 48.9% 48.9%
Operating Margin 29.6% 26.6% 11.5% 10.7%
Profit Margin 29.3% 27.8% 10.8% 9.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 36.60M 40.52M 91.03M 78.58M
Gross Profit 20.90M 23.14M 44.52M 38.43M
Operating Income 10.83M 10.79M 10.51M 8.39M
Net Income 10.72M 10.68M 9.79M 7.70M
Gross Margin 57.1% 57.1% 48.9% 48.9%
Operating Margin 29.6% 26.6% 11.5% 10.7%
Profit Margin 29.3% 27.8% 10.8% 9.8%
Rev Growth -9.7% -9.7% +19.7% +6.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 56.05M 53.25M
Total Equity — — 101.18M 111.70M
D/E Ratio — — 0.55 0.48
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 12.82M 13.49M 14.55M 11.68M
Free Cash Flow — — 8.08M 6.39M